Global Antiviral Drug Packaging Market Growth 2026-2032
The global Antiviral Drug Packaging market size is predicted to grow from US$ 28630 million in 2025 to US$ 37170 million in 2032; it is expected to grow at a CAGR of 3.9% from 2026 to 2032.
Antiviral drug packaging is specially designed for packaging antiviral drugs. Antiviral drugs are a class of medication used specifically for treating viral infections such as influenza, herpes virus infections, viral hepatitis and human immunodeficiency virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Antiviral Drug Packaging Industry Forecast” looks at past sales and reviews total world Antiviral Drug Packaging sales in 2025, providing a comprehensive analysis by region and market sector of projected Antiviral Drug Packaging sales for 2026 through 2032. With Antiviral Drug Packaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antiviral Drug Packaging industry.
This Insight Report provides a comprehensive analysis of the global Antiviral Drug Packaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antiviral Drug Packaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antiviral Drug Packaging market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antiviral Drug Packaging and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antiviral Drug Packaging.
This report presents a comprehensive overview, market shares, and growth opportunities of Antiviral Drug Packaging market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Antiviral Drug Packaging market?
What factors are driving Antiviral Drug Packaging market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antiviral Drug Packaging market opportunities vary by end market size?
How does Antiviral Drug Packaging break out by Type, by Application?
Antiviral drug packaging is specially designed for packaging antiviral drugs. Antiviral drugs are a class of medication used specifically for treating viral infections such as influenza, herpes virus infections, viral hepatitis and human immunodeficiency virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Antiviral Drug Packaging Industry Forecast” looks at past sales and reviews total world Antiviral Drug Packaging sales in 2025, providing a comprehensive analysis by region and market sector of projected Antiviral Drug Packaging sales for 2026 through 2032. With Antiviral Drug Packaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antiviral Drug Packaging industry.
This Insight Report provides a comprehensive analysis of the global Antiviral Drug Packaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antiviral Drug Packaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antiviral Drug Packaging market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antiviral Drug Packaging and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antiviral Drug Packaging.
This report presents a comprehensive overview, market shares, and growth opportunities of Antiviral Drug Packaging market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Rigid Plastic
- Flexible Blister Foils
- Others
- Pharmaceuticals
- Healthcare
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Avery Dennison Corporation
- E.I. du Pont de Nemours
- CCL Industries Inc
- BioCote
- Avient
- Mondi
- Biomaster
- BASF
- Lonza
- Takex Labo Co. Ltd
- Berry
- Lageen Tubes.
What is the 10-year outlook for the global Antiviral Drug Packaging market?
What factors are driving Antiviral Drug Packaging market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antiviral Drug Packaging market opportunities vary by end market size?
How does Antiviral Drug Packaging break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antiviral Drug Packaging Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Antiviral Drug Packaging by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Antiviral Drug Packaging by Country/Region, 2021, 2025 & 2032
2.2 Antiviral Drug Packaging Segment by Type
2.2.1 Rigid Plastic
2.2.2 Flexible Blister Foils
2.2.3 Others
2.2.4 Antiviral Drug Packaging Sales by Type
2.2.4.1 Global Antiviral Drug Packaging Sales Market Share by Type (2021-2026)
2.2.4.2 Global Antiviral Drug Packaging Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Antiviral Drug Packaging Sale Price by Type (2021-2026)
2.3 Antiviral Drug Packaging Segment by Application
2.3.1 Pharmaceuticals
2.3.2 Healthcare
2.3.3 Antiviral Drug Packaging Sales by Application
2.3.3.1 Global Antiviral Drug Packaging Sale Market Share by Application (2021-2026)
2.3.3.2 Global Antiviral Drug Packaging Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Antiviral Drug Packaging Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Antiviral Drug Packaging Breakdown Data by Company
3.1.1 Global Antiviral Drug Packaging Annual Sales by Company (2021-2026)
3.1.2 Global Antiviral Drug Packaging Sales Market Share by Company (2021-2026)
3.2 Global Antiviral Drug Packaging Annual Revenue by Company (2021-2026)
3.2.1 Global Antiviral Drug Packaging Revenue by Company (2021-2026)
3.2.2 Global Antiviral Drug Packaging Revenue Market Share by Company (2021-2026)
3.3 Global Antiviral Drug Packaging Sale Price by Company
3.4 Key Manufacturers Antiviral Drug Packaging Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antiviral Drug Packaging Product Location Distribution
3.4.2 Players Antiviral Drug Packaging Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTIVIRAL DRUG PACKAGING BY GEOGRAPHIC REGION
4.1 World Historic Antiviral Drug Packaging Market Size by Geographic Region (2021-2026)
4.1.1 Global Antiviral Drug Packaging Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Antiviral Drug Packaging Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Antiviral Drug Packaging Market Size by Country/Region (2021-2026)
4.2.1 Global Antiviral Drug Packaging Annual Sales by Country/Region (2021-2026)
4.2.2 Global Antiviral Drug Packaging Annual Revenue by Country/Region (2021-2026)
4.3 Americas Antiviral Drug Packaging Sales Growth
4.4 APAC Antiviral Drug Packaging Sales Growth
4.5 Europe Antiviral Drug Packaging Sales Growth
4.6 Middle East & Africa Antiviral Drug Packaging Sales Growth
5 AMERICAS
5.1 Americas Antiviral Drug Packaging Sales by Country
5.1.1 Americas Antiviral Drug Packaging Sales by Country (2021-2026)
5.1.2 Americas Antiviral Drug Packaging Revenue by Country (2021-2026)
5.2 Americas Antiviral Drug Packaging Sales by Type (2021-2026)
5.3 Americas Antiviral Drug Packaging Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antiviral Drug Packaging Sales by Region
6.1.1 APAC Antiviral Drug Packaging Sales by Region (2021-2026)
6.1.2 APAC Antiviral Drug Packaging Revenue by Region (2021-2026)
6.2 APAC Antiviral Drug Packaging Sales by Type (2021-2026)
6.3 APAC Antiviral Drug Packaging Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antiviral Drug Packaging by Country
7.1.1 Europe Antiviral Drug Packaging Sales by Country (2021-2026)
7.1.2 Europe Antiviral Drug Packaging Revenue by Country (2021-2026)
7.2 Europe Antiviral Drug Packaging Sales by Type (2021-2026)
7.3 Europe Antiviral Drug Packaging Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antiviral Drug Packaging by Country
8.1.1 Middle East & Africa Antiviral Drug Packaging Sales by Country (2021-2026)
8.1.2 Middle East & Africa Antiviral Drug Packaging Revenue by Country (2021-2026)
8.2 Middle East & Africa Antiviral Drug Packaging Sales by Type (2021-2026)
8.3 Middle East & Africa Antiviral Drug Packaging Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antiviral Drug Packaging
10.3 Manufacturing Process Analysis of Antiviral Drug Packaging
10.4 Industry Chain Structure of Antiviral Drug Packaging
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antiviral Drug Packaging Distributors
11.3 Antiviral Drug Packaging Customer
12 WORLD FORECAST REVIEW FOR ANTIVIRAL DRUG PACKAGING BY GEOGRAPHIC REGION
12.1 Global Antiviral Drug Packaging Market Size Forecast by Region
12.1.1 Global Antiviral Drug Packaging Forecast by Region (2027-2032)
12.1.2 Global Antiviral Drug Packaging Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Antiviral Drug Packaging Forecast by Type (2027-2032)
12.7 Global Antiviral Drug Packaging Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Avery Dennison Corporation
13.1.1 Avery Dennison Corporation Company Information
13.1.2 Avery Dennison Corporation Antiviral Drug Packaging Product Portfolios and Specifications
13.1.3 Avery Dennison Corporation Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Avery Dennison Corporation Main Business Overview
13.1.5 Avery Dennison Corporation Latest Developments
13.2 E.I. du Pont de Nemours
13.2.1 E.I. du Pont de Nemours Company Information
13.2.2 E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolios and Specifications
13.2.3 E.I. du Pont de Nemours Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 E.I. du Pont de Nemours Main Business Overview
13.2.5 E.I. du Pont de Nemours Latest Developments
13.3 CCL Industries Inc
13.3.1 CCL Industries Inc Company Information
13.3.2 CCL Industries Inc Antiviral Drug Packaging Product Portfolios and Specifications
13.3.3 CCL Industries Inc Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CCL Industries Inc Main Business Overview
13.3.5 CCL Industries Inc Latest Developments
13.4 BioCote
13.4.1 BioCote Company Information
13.4.2 BioCote Antiviral Drug Packaging Product Portfolios and Specifications
13.4.3 BioCote Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BioCote Main Business Overview
13.4.5 BioCote Latest Developments
13.5 Avient
13.5.1 Avient Company Information
13.5.2 Avient Antiviral Drug Packaging Product Portfolios and Specifications
13.5.3 Avient Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Avient Main Business Overview
13.5.5 Avient Latest Developments
13.6 Mondi
13.6.1 Mondi Company Information
13.6.2 Mondi Antiviral Drug Packaging Product Portfolios and Specifications
13.6.3 Mondi Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Mondi Main Business Overview
13.6.5 Mondi Latest Developments
13.7 Biomaster
13.7.1 Biomaster Company Information
13.7.2 Biomaster Antiviral Drug Packaging Product Portfolios and Specifications
13.7.3 Biomaster Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Biomaster Main Business Overview
13.7.5 Biomaster Latest Developments
13.8 BASF
13.8.1 BASF Company Information
13.8.2 BASF Antiviral Drug Packaging Product Portfolios and Specifications
13.8.3 BASF Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 BASF Main Business Overview
13.8.5 BASF Latest Developments
13.9 Lonza
13.9.1 Lonza Company Information
13.9.2 Lonza Antiviral Drug Packaging Product Portfolios and Specifications
13.9.3 Lonza Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Lonza Main Business Overview
13.9.5 Lonza Latest Developments
13.10 Takex Labo Co. Ltd
13.10.1 Takex Labo Co. Ltd Company Information
13.10.2 Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolios and Specifications
13.10.3 Takex Labo Co. Ltd Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Takex Labo Co. Ltd Main Business Overview
13.10.5 Takex Labo Co. Ltd Latest Developments
13.11 Berry
13.11.1 Berry Company Information
13.11.2 Berry Antiviral Drug Packaging Product Portfolios and Specifications
13.11.3 Berry Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Berry Main Business Overview
13.11.5 Berry Latest Developments
13.12 Lageen Tubes.
13.12.1 Lageen Tubes. Company Information
13.12.2 Lageen Tubes. Antiviral Drug Packaging Product Portfolios and Specifications
13.12.3 Lageen Tubes. Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Lageen Tubes. Main Business Overview
13.12.5 Lageen Tubes. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antiviral Drug Packaging Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Antiviral Drug Packaging by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Antiviral Drug Packaging by Country/Region, 2021, 2025 & 2032
2.2 Antiviral Drug Packaging Segment by Type
2.2.1 Rigid Plastic
2.2.2 Flexible Blister Foils
2.2.3 Others
2.2.4 Antiviral Drug Packaging Sales by Type
2.2.4.1 Global Antiviral Drug Packaging Sales Market Share by Type (2021-2026)
2.2.4.2 Global Antiviral Drug Packaging Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Antiviral Drug Packaging Sale Price by Type (2021-2026)
2.3 Antiviral Drug Packaging Segment by Application
2.3.1 Pharmaceuticals
2.3.2 Healthcare
2.3.3 Antiviral Drug Packaging Sales by Application
2.3.3.1 Global Antiviral Drug Packaging Sale Market Share by Application (2021-2026)
2.3.3.2 Global Antiviral Drug Packaging Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Antiviral Drug Packaging Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Antiviral Drug Packaging Breakdown Data by Company
3.1.1 Global Antiviral Drug Packaging Annual Sales by Company (2021-2026)
3.1.2 Global Antiviral Drug Packaging Sales Market Share by Company (2021-2026)
3.2 Global Antiviral Drug Packaging Annual Revenue by Company (2021-2026)
3.2.1 Global Antiviral Drug Packaging Revenue by Company (2021-2026)
3.2.2 Global Antiviral Drug Packaging Revenue Market Share by Company (2021-2026)
3.3 Global Antiviral Drug Packaging Sale Price by Company
3.4 Key Manufacturers Antiviral Drug Packaging Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antiviral Drug Packaging Product Location Distribution
3.4.2 Players Antiviral Drug Packaging Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTIVIRAL DRUG PACKAGING BY GEOGRAPHIC REGION
4.1 World Historic Antiviral Drug Packaging Market Size by Geographic Region (2021-2026)
4.1.1 Global Antiviral Drug Packaging Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Antiviral Drug Packaging Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Antiviral Drug Packaging Market Size by Country/Region (2021-2026)
4.2.1 Global Antiviral Drug Packaging Annual Sales by Country/Region (2021-2026)
4.2.2 Global Antiviral Drug Packaging Annual Revenue by Country/Region (2021-2026)
4.3 Americas Antiviral Drug Packaging Sales Growth
4.4 APAC Antiviral Drug Packaging Sales Growth
4.5 Europe Antiviral Drug Packaging Sales Growth
4.6 Middle East & Africa Antiviral Drug Packaging Sales Growth
5 AMERICAS
5.1 Americas Antiviral Drug Packaging Sales by Country
5.1.1 Americas Antiviral Drug Packaging Sales by Country (2021-2026)
5.1.2 Americas Antiviral Drug Packaging Revenue by Country (2021-2026)
5.2 Americas Antiviral Drug Packaging Sales by Type (2021-2026)
5.3 Americas Antiviral Drug Packaging Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antiviral Drug Packaging Sales by Region
6.1.1 APAC Antiviral Drug Packaging Sales by Region (2021-2026)
6.1.2 APAC Antiviral Drug Packaging Revenue by Region (2021-2026)
6.2 APAC Antiviral Drug Packaging Sales by Type (2021-2026)
6.3 APAC Antiviral Drug Packaging Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antiviral Drug Packaging by Country
7.1.1 Europe Antiviral Drug Packaging Sales by Country (2021-2026)
7.1.2 Europe Antiviral Drug Packaging Revenue by Country (2021-2026)
7.2 Europe Antiviral Drug Packaging Sales by Type (2021-2026)
7.3 Europe Antiviral Drug Packaging Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antiviral Drug Packaging by Country
8.1.1 Middle East & Africa Antiviral Drug Packaging Sales by Country (2021-2026)
8.1.2 Middle East & Africa Antiviral Drug Packaging Revenue by Country (2021-2026)
8.2 Middle East & Africa Antiviral Drug Packaging Sales by Type (2021-2026)
8.3 Middle East & Africa Antiviral Drug Packaging Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antiviral Drug Packaging
10.3 Manufacturing Process Analysis of Antiviral Drug Packaging
10.4 Industry Chain Structure of Antiviral Drug Packaging
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antiviral Drug Packaging Distributors
11.3 Antiviral Drug Packaging Customer
12 WORLD FORECAST REVIEW FOR ANTIVIRAL DRUG PACKAGING BY GEOGRAPHIC REGION
12.1 Global Antiviral Drug Packaging Market Size Forecast by Region
12.1.1 Global Antiviral Drug Packaging Forecast by Region (2027-2032)
12.1.2 Global Antiviral Drug Packaging Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Antiviral Drug Packaging Forecast by Type (2027-2032)
12.7 Global Antiviral Drug Packaging Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Avery Dennison Corporation
13.1.1 Avery Dennison Corporation Company Information
13.1.2 Avery Dennison Corporation Antiviral Drug Packaging Product Portfolios and Specifications
13.1.3 Avery Dennison Corporation Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Avery Dennison Corporation Main Business Overview
13.1.5 Avery Dennison Corporation Latest Developments
13.2 E.I. du Pont de Nemours
13.2.1 E.I. du Pont de Nemours Company Information
13.2.2 E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolios and Specifications
13.2.3 E.I. du Pont de Nemours Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 E.I. du Pont de Nemours Main Business Overview
13.2.5 E.I. du Pont de Nemours Latest Developments
13.3 CCL Industries Inc
13.3.1 CCL Industries Inc Company Information
13.3.2 CCL Industries Inc Antiviral Drug Packaging Product Portfolios and Specifications
13.3.3 CCL Industries Inc Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CCL Industries Inc Main Business Overview
13.3.5 CCL Industries Inc Latest Developments
13.4 BioCote
13.4.1 BioCote Company Information
13.4.2 BioCote Antiviral Drug Packaging Product Portfolios and Specifications
13.4.3 BioCote Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BioCote Main Business Overview
13.4.5 BioCote Latest Developments
13.5 Avient
13.5.1 Avient Company Information
13.5.2 Avient Antiviral Drug Packaging Product Portfolios and Specifications
13.5.3 Avient Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Avient Main Business Overview
13.5.5 Avient Latest Developments
13.6 Mondi
13.6.1 Mondi Company Information
13.6.2 Mondi Antiviral Drug Packaging Product Portfolios and Specifications
13.6.3 Mondi Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Mondi Main Business Overview
13.6.5 Mondi Latest Developments
13.7 Biomaster
13.7.1 Biomaster Company Information
13.7.2 Biomaster Antiviral Drug Packaging Product Portfolios and Specifications
13.7.3 Biomaster Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Biomaster Main Business Overview
13.7.5 Biomaster Latest Developments
13.8 BASF
13.8.1 BASF Company Information
13.8.2 BASF Antiviral Drug Packaging Product Portfolios and Specifications
13.8.3 BASF Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 BASF Main Business Overview
13.8.5 BASF Latest Developments
13.9 Lonza
13.9.1 Lonza Company Information
13.9.2 Lonza Antiviral Drug Packaging Product Portfolios and Specifications
13.9.3 Lonza Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Lonza Main Business Overview
13.9.5 Lonza Latest Developments
13.10 Takex Labo Co. Ltd
13.10.1 Takex Labo Co. Ltd Company Information
13.10.2 Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolios and Specifications
13.10.3 Takex Labo Co. Ltd Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Takex Labo Co. Ltd Main Business Overview
13.10.5 Takex Labo Co. Ltd Latest Developments
13.11 Berry
13.11.1 Berry Company Information
13.11.2 Berry Antiviral Drug Packaging Product Portfolios and Specifications
13.11.3 Berry Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Berry Main Business Overview
13.11.5 Berry Latest Developments
13.12 Lageen Tubes.
13.12.1 Lageen Tubes. Company Information
13.12.2 Lageen Tubes. Antiviral Drug Packaging Product Portfolios and Specifications
13.12.3 Lageen Tubes. Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Lageen Tubes. Main Business Overview
13.12.5 Lageen Tubes. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antiviral Drug Packaging Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Antiviral Drug Packaging Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Rigid Plastic
Table 4. Major Players of Flexible Blister Foils
Table 5. Major Players of Others
Table 6. Global Antiviral Drug Packaging Sales by Type (2021-2026) & (K Units)
Table 7. Global Antiviral Drug Packaging Sales Market Share by Type (2021-2026)
Table 8. Global Antiviral Drug Packaging Revenue by Type (2021-2026) & ($ million)
Table 9. Global Antiviral Drug Packaging Revenue Market Share by Type (2021-2026)
Table 10. Global Antiviral Drug Packaging Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Antiviral Drug Packaging Sale by Application (2021-2026) & (K Units)
Table 12. Global Antiviral Drug Packaging Sale Market Share by Application (2021-2026)
Table 13. Global Antiviral Drug Packaging Revenue by Application (2021-2026) & ($ million)
Table 14. Global Antiviral Drug Packaging Revenue Market Share by Application (2021-2026)
Table 15. Global Antiviral Drug Packaging Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Antiviral Drug Packaging Sales by Company (2021-2026) & (K Units)
Table 17. Global Antiviral Drug Packaging Sales Market Share by Company (2021-2026)
Table 18. Global Antiviral Drug Packaging Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Antiviral Drug Packaging Revenue Market Share by Company (2021-2026)
Table 20. Global Antiviral Drug Packaging Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Antiviral Drug Packaging Producing Area Distribution and Sales Area
Table 22. Players Antiviral Drug Packaging Products Offered
Table 23. Antiviral Drug Packaging Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Antiviral Drug Packaging Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Antiviral Drug Packaging Sales Market Share Geographic Region (2021-2026)
Table 28. Global Antiviral Drug Packaging Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Antiviral Drug Packaging Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Antiviral Drug Packaging Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Antiviral Drug Packaging Sales Market Share by Country/Region (2021-2026)
Table 32. Global Antiviral Drug Packaging Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Antiviral Drug Packaging Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Antiviral Drug Packaging Sales by Country (2021-2026) & (K Units)
Table 35. Americas Antiviral Drug Packaging Sales Market Share by Country (2021-2026)
Table 36. Americas Antiviral Drug Packaging Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Antiviral Drug Packaging Sales by Type (2021-2026) & (K Units)
Table 38. Americas Antiviral Drug Packaging Sales by Application (2021-2026) & (K Units)
Table 39. APAC Antiviral Drug Packaging Sales by Region (2021-2026) & (K Units)
Table 40. APAC Antiviral Drug Packaging Sales Market Share by Region (2021-2026)
Table 41. APAC Antiviral Drug Packaging Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Antiviral Drug Packaging Sales by Type (2021-2026) & (K Units)
Table 43. APAC Antiviral Drug Packaging Sales by Application (2021-2026) & (K Units)
Table 44. Europe Antiviral Drug Packaging Sales by Country (2021-2026) & (K Units)
Table 45. Europe Antiviral Drug Packaging Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Antiviral Drug Packaging Sales by Type (2021-2026) & (K Units)
Table 47. Europe Antiviral Drug Packaging Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Antiviral Drug Packaging Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Antiviral Drug Packaging Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Antiviral Drug Packaging Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Antiviral Drug Packaging Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Antiviral Drug Packaging
Table 53. Key Market Challenges & Risks of Antiviral Drug Packaging
Table 54. Key Industry Trends of Antiviral Drug Packaging
Table 55. Antiviral Drug Packaging Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Antiviral Drug Packaging Distributors List
Table 58. Antiviral Drug Packaging Customer List
Table 59. Global Antiviral Drug Packaging Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Antiviral Drug Packaging Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Antiviral Drug Packaging Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Antiviral Drug Packaging Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Antiviral Drug Packaging Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Antiviral Drug Packaging Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Antiviral Drug Packaging Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Antiviral Drug Packaging Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Antiviral Drug Packaging Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Antiviral Drug Packaging Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Antiviral Drug Packaging Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Antiviral Drug Packaging Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Antiviral Drug Packaging Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Antiviral Drug Packaging Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Avery Dennison Corporation Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 74. Avery Dennison Corporation Antiviral Drug Packaging Product Portfolios and Specifications
Table 75. Avery Dennison Corporation Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Avery Dennison Corporation Main Business
Table 77. Avery Dennison Corporation Latest Developments
Table 78. E.I. du Pont de Nemours Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 79. E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolios and Specifications
Table 80. E.I. du Pont de Nemours Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. E.I. du Pont de Nemours Main Business
Table 82. E.I. du Pont de Nemours Latest Developments
Table 83. CCL Industries Inc Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 84. CCL Industries Inc Antiviral Drug Packaging Product Portfolios and Specifications
Table 85. CCL Industries Inc Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. CCL Industries Inc Main Business
Table 87. CCL Industries Inc Latest Developments
Table 88. BioCote Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 89. BioCote Antiviral Drug Packaging Product Portfolios and Specifications
Table 90. BioCote Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. BioCote Main Business
Table 92. BioCote Latest Developments
Table 93. Avient Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 94. Avient Antiviral Drug Packaging Product Portfolios and Specifications
Table 95. Avient Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Avient Main Business
Table 97. Avient Latest Developments
Table 98. Mondi Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 99. Mondi Antiviral Drug Packaging Product Portfolios and Specifications
Table 100. Mondi Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Mondi Main Business
Table 102. Mondi Latest Developments
Table 103. Biomaster Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 104. Biomaster Antiviral Drug Packaging Product Portfolios and Specifications
Table 105. Biomaster Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Biomaster Main Business
Table 107. Biomaster Latest Developments
Table 108. BASF Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 109. BASF Antiviral Drug Packaging Product Portfolios and Specifications
Table 110. BASF Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. BASF Main Business
Table 112. BASF Latest Developments
Table 113. Lonza Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 114. Lonza Antiviral Drug Packaging Product Portfolios and Specifications
Table 115. Lonza Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Lonza Main Business
Table 117. Lonza Latest Developments
Table 118. Takex Labo Co. Ltd Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 119. Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolios and Specifications
Table 120. Takex Labo Co. Ltd Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Takex Labo Co. Ltd Main Business
Table 122. Takex Labo Co. Ltd Latest Developments
Table 123. Berry Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 124. Berry Antiviral Drug Packaging Product Portfolios and Specifications
Table 125. Berry Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Berry Main Business
Table 127. Berry Latest Developments
Table 128. Lageen Tubes. Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 129. Lageen Tubes. Antiviral Drug Packaging Product Portfolios and Specifications
Table 130. Lageen Tubes. Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Lageen Tubes. Main Business
Table 132. Lageen Tubes. Latest Developments
Table 1. Antiviral Drug Packaging Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Antiviral Drug Packaging Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Rigid Plastic
Table 4. Major Players of Flexible Blister Foils
Table 5. Major Players of Others
Table 6. Global Antiviral Drug Packaging Sales by Type (2021-2026) & (K Units)
Table 7. Global Antiviral Drug Packaging Sales Market Share by Type (2021-2026)
Table 8. Global Antiviral Drug Packaging Revenue by Type (2021-2026) & ($ million)
Table 9. Global Antiviral Drug Packaging Revenue Market Share by Type (2021-2026)
Table 10. Global Antiviral Drug Packaging Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Antiviral Drug Packaging Sale by Application (2021-2026) & (K Units)
Table 12. Global Antiviral Drug Packaging Sale Market Share by Application (2021-2026)
Table 13. Global Antiviral Drug Packaging Revenue by Application (2021-2026) & ($ million)
Table 14. Global Antiviral Drug Packaging Revenue Market Share by Application (2021-2026)
Table 15. Global Antiviral Drug Packaging Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Antiviral Drug Packaging Sales by Company (2021-2026) & (K Units)
Table 17. Global Antiviral Drug Packaging Sales Market Share by Company (2021-2026)
Table 18. Global Antiviral Drug Packaging Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Antiviral Drug Packaging Revenue Market Share by Company (2021-2026)
Table 20. Global Antiviral Drug Packaging Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Antiviral Drug Packaging Producing Area Distribution and Sales Area
Table 22. Players Antiviral Drug Packaging Products Offered
Table 23. Antiviral Drug Packaging Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Antiviral Drug Packaging Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Antiviral Drug Packaging Sales Market Share Geographic Region (2021-2026)
Table 28. Global Antiviral Drug Packaging Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Antiviral Drug Packaging Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Antiviral Drug Packaging Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Antiviral Drug Packaging Sales Market Share by Country/Region (2021-2026)
Table 32. Global Antiviral Drug Packaging Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Antiviral Drug Packaging Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Antiviral Drug Packaging Sales by Country (2021-2026) & (K Units)
Table 35. Americas Antiviral Drug Packaging Sales Market Share by Country (2021-2026)
Table 36. Americas Antiviral Drug Packaging Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Antiviral Drug Packaging Sales by Type (2021-2026) & (K Units)
Table 38. Americas Antiviral Drug Packaging Sales by Application (2021-2026) & (K Units)
Table 39. APAC Antiviral Drug Packaging Sales by Region (2021-2026) & (K Units)
Table 40. APAC Antiviral Drug Packaging Sales Market Share by Region (2021-2026)
Table 41. APAC Antiviral Drug Packaging Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Antiviral Drug Packaging Sales by Type (2021-2026) & (K Units)
Table 43. APAC Antiviral Drug Packaging Sales by Application (2021-2026) & (K Units)
Table 44. Europe Antiviral Drug Packaging Sales by Country (2021-2026) & (K Units)
Table 45. Europe Antiviral Drug Packaging Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Antiviral Drug Packaging Sales by Type (2021-2026) & (K Units)
Table 47. Europe Antiviral Drug Packaging Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Antiviral Drug Packaging Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Antiviral Drug Packaging Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Antiviral Drug Packaging Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Antiviral Drug Packaging Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Antiviral Drug Packaging
Table 53. Key Market Challenges & Risks of Antiviral Drug Packaging
Table 54. Key Industry Trends of Antiviral Drug Packaging
Table 55. Antiviral Drug Packaging Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Antiviral Drug Packaging Distributors List
Table 58. Antiviral Drug Packaging Customer List
Table 59. Global Antiviral Drug Packaging Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Antiviral Drug Packaging Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Antiviral Drug Packaging Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Antiviral Drug Packaging Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Antiviral Drug Packaging Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Antiviral Drug Packaging Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Antiviral Drug Packaging Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Antiviral Drug Packaging Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Antiviral Drug Packaging Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Antiviral Drug Packaging Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Antiviral Drug Packaging Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Antiviral Drug Packaging Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Antiviral Drug Packaging Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Antiviral Drug Packaging Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Avery Dennison Corporation Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 74. Avery Dennison Corporation Antiviral Drug Packaging Product Portfolios and Specifications
Table 75. Avery Dennison Corporation Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Avery Dennison Corporation Main Business
Table 77. Avery Dennison Corporation Latest Developments
Table 78. E.I. du Pont de Nemours Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 79. E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolios and Specifications
Table 80. E.I. du Pont de Nemours Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. E.I. du Pont de Nemours Main Business
Table 82. E.I. du Pont de Nemours Latest Developments
Table 83. CCL Industries Inc Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 84. CCL Industries Inc Antiviral Drug Packaging Product Portfolios and Specifications
Table 85. CCL Industries Inc Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. CCL Industries Inc Main Business
Table 87. CCL Industries Inc Latest Developments
Table 88. BioCote Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 89. BioCote Antiviral Drug Packaging Product Portfolios and Specifications
Table 90. BioCote Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. BioCote Main Business
Table 92. BioCote Latest Developments
Table 93. Avient Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 94. Avient Antiviral Drug Packaging Product Portfolios and Specifications
Table 95. Avient Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Avient Main Business
Table 97. Avient Latest Developments
Table 98. Mondi Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 99. Mondi Antiviral Drug Packaging Product Portfolios and Specifications
Table 100. Mondi Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Mondi Main Business
Table 102. Mondi Latest Developments
Table 103. Biomaster Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 104. Biomaster Antiviral Drug Packaging Product Portfolios and Specifications
Table 105. Biomaster Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Biomaster Main Business
Table 107. Biomaster Latest Developments
Table 108. BASF Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 109. BASF Antiviral Drug Packaging Product Portfolios and Specifications
Table 110. BASF Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. BASF Main Business
Table 112. BASF Latest Developments
Table 113. Lonza Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 114. Lonza Antiviral Drug Packaging Product Portfolios and Specifications
Table 115. Lonza Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Lonza Main Business
Table 117. Lonza Latest Developments
Table 118. Takex Labo Co. Ltd Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 119. Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolios and Specifications
Table 120. Takex Labo Co. Ltd Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Takex Labo Co. Ltd Main Business
Table 122. Takex Labo Co. Ltd Latest Developments
Table 123. Berry Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 124. Berry Antiviral Drug Packaging Product Portfolios and Specifications
Table 125. Berry Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Berry Main Business
Table 127. Berry Latest Developments
Table 128. Lageen Tubes. Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 129. Lageen Tubes. Antiviral Drug Packaging Product Portfolios and Specifications
Table 130. Lageen Tubes. Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Lageen Tubes. Main Business
Table 132. Lageen Tubes. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Antiviral Drug Packaging
Figure 2. Antiviral Drug Packaging Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antiviral Drug Packaging Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Antiviral Drug Packaging Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Antiviral Drug Packaging Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Antiviral Drug Packaging Sales Market Share by Country/Region (2025)
Figure 10. Antiviral Drug Packaging Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Rigid Plastic
Figure 12. Product Picture of Flexible Blister Foils
Figure 13. Product Picture of Others
Figure 14. Global Antiviral Drug Packaging Sales Market Share by Type in 2026
Figure 15. Global Antiviral Drug Packaging Revenue Market Share by Type (2021-2026)
Figure 16. Antiviral Drug Packaging Consumed in Pharmaceuticals
Figure 17. Global Antiviral Drug Packaging Market: Pharmaceuticals (2021-2026) & (K Units)
Figure 18. Antiviral Drug Packaging Consumed in Healthcare
Figure 19. Global Antiviral Drug Packaging Market: Healthcare (2021-2026) & (K Units)
Figure 20. Global Antiviral Drug Packaging Sale Market Share by Application (2025)
Figure 21. Global Antiviral Drug Packaging Revenue Market Share by Application in 2026
Figure 22. Antiviral Drug Packaging Sales by Company in 2026 (K Units)
Figure 23. Global Antiviral Drug Packaging Sales Market Share by Company in 2026
Figure 24. Antiviral Drug Packaging Revenue by Company in 2026 ($ millions)
Figure 25. Global Antiviral Drug Packaging Revenue Market Share by Company in 2026
Figure 26. Global Antiviral Drug Packaging Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Antiviral Drug Packaging Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Antiviral Drug Packaging Sales 2021-2026 (K Units)
Figure 29. Americas Antiviral Drug Packaging Revenue 2021-2026 ($ millions)
Figure 30. APAC Antiviral Drug Packaging Sales 2021-2026 (K Units)
Figure 31. APAC Antiviral Drug Packaging Revenue 2021-2026 ($ millions)
Figure 32. Europe Antiviral Drug Packaging Sales 2021-2026 (K Units)
Figure 33. Europe Antiviral Drug Packaging Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Antiviral Drug Packaging Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Antiviral Drug Packaging Revenue 2021-2026 ($ millions)
Figure 36. Americas Antiviral Drug Packaging Sales Market Share by Country in 2026
Figure 37. Americas Antiviral Drug Packaging Revenue Market Share by Country (2021-2026)
Figure 38. Americas Antiviral Drug Packaging Sales Market Share by Type (2021-2026)
Figure 39. Americas Antiviral Drug Packaging Sales Market Share by Application (2021-2026)
Figure 40. United States Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Antiviral Drug Packaging Sales Market Share by Region in 2026
Figure 45. APAC Antiviral Drug Packaging Revenue Market Share by Region (2021-2026)
Figure 46. APAC Antiviral Drug Packaging Sales Market Share by Type (2021-2026)
Figure 47. APAC Antiviral Drug Packaging Sales Market Share by Application (2021-2026)
Figure 48. China Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 52. India Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Antiviral Drug Packaging Sales Market Share by Country in 2026
Figure 56. Europe Antiviral Drug Packaging Revenue Market Share by Country (2021-2026)
Figure 57. Europe Antiviral Drug Packaging Sales Market Share by Type (2021-2026)
Figure 58. Europe Antiviral Drug Packaging Sales Market Share by Application (2021-2026)
Figure 59. Germany Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 60. France Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Antiviral Drug Packaging Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Antiviral Drug Packaging Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Antiviral Drug Packaging Sales Market Share by Application (2021-2026)
Figure 67. Egypt Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Antiviral Drug Packaging in 2026
Figure 73. Manufacturing Process Analysis of Antiviral Drug Packaging
Figure 74. Industry Chain Structure of Antiviral Drug Packaging
Figure 75. Channels of Distribution
Figure 76. Global Antiviral Drug Packaging Sales Market Forecast by Region (2027-2032)
Figure 77. Global Antiviral Drug Packaging Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Antiviral Drug Packaging Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Antiviral Drug Packaging Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Antiviral Drug Packaging Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Antiviral Drug Packaging Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Antiviral Drug Packaging
Figure 2. Antiviral Drug Packaging Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antiviral Drug Packaging Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Antiviral Drug Packaging Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Antiviral Drug Packaging Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Antiviral Drug Packaging Sales Market Share by Country/Region (2025)
Figure 10. Antiviral Drug Packaging Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Rigid Plastic
Figure 12. Product Picture of Flexible Blister Foils
Figure 13. Product Picture of Others
Figure 14. Global Antiviral Drug Packaging Sales Market Share by Type in 2026
Figure 15. Global Antiviral Drug Packaging Revenue Market Share by Type (2021-2026)
Figure 16. Antiviral Drug Packaging Consumed in Pharmaceuticals
Figure 17. Global Antiviral Drug Packaging Market: Pharmaceuticals (2021-2026) & (K Units)
Figure 18. Antiviral Drug Packaging Consumed in Healthcare
Figure 19. Global Antiviral Drug Packaging Market: Healthcare (2021-2026) & (K Units)
Figure 20. Global Antiviral Drug Packaging Sale Market Share by Application (2025)
Figure 21. Global Antiviral Drug Packaging Revenue Market Share by Application in 2026
Figure 22. Antiviral Drug Packaging Sales by Company in 2026 (K Units)
Figure 23. Global Antiviral Drug Packaging Sales Market Share by Company in 2026
Figure 24. Antiviral Drug Packaging Revenue by Company in 2026 ($ millions)
Figure 25. Global Antiviral Drug Packaging Revenue Market Share by Company in 2026
Figure 26. Global Antiviral Drug Packaging Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Antiviral Drug Packaging Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Antiviral Drug Packaging Sales 2021-2026 (K Units)
Figure 29. Americas Antiviral Drug Packaging Revenue 2021-2026 ($ millions)
Figure 30. APAC Antiviral Drug Packaging Sales 2021-2026 (K Units)
Figure 31. APAC Antiviral Drug Packaging Revenue 2021-2026 ($ millions)
Figure 32. Europe Antiviral Drug Packaging Sales 2021-2026 (K Units)
Figure 33. Europe Antiviral Drug Packaging Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Antiviral Drug Packaging Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Antiviral Drug Packaging Revenue 2021-2026 ($ millions)
Figure 36. Americas Antiviral Drug Packaging Sales Market Share by Country in 2026
Figure 37. Americas Antiviral Drug Packaging Revenue Market Share by Country (2021-2026)
Figure 38. Americas Antiviral Drug Packaging Sales Market Share by Type (2021-2026)
Figure 39. Americas Antiviral Drug Packaging Sales Market Share by Application (2021-2026)
Figure 40. United States Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Antiviral Drug Packaging Sales Market Share by Region in 2026
Figure 45. APAC Antiviral Drug Packaging Revenue Market Share by Region (2021-2026)
Figure 46. APAC Antiviral Drug Packaging Sales Market Share by Type (2021-2026)
Figure 47. APAC Antiviral Drug Packaging Sales Market Share by Application (2021-2026)
Figure 48. China Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 52. India Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Antiviral Drug Packaging Sales Market Share by Country in 2026
Figure 56. Europe Antiviral Drug Packaging Revenue Market Share by Country (2021-2026)
Figure 57. Europe Antiviral Drug Packaging Sales Market Share by Type (2021-2026)
Figure 58. Europe Antiviral Drug Packaging Sales Market Share by Application (2021-2026)
Figure 59. Germany Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 60. France Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Antiviral Drug Packaging Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Antiviral Drug Packaging Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Antiviral Drug Packaging Sales Market Share by Application (2021-2026)
Figure 67. Egypt Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Antiviral Drug Packaging Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Antiviral Drug Packaging in 2026
Figure 73. Manufacturing Process Analysis of Antiviral Drug Packaging
Figure 74. Industry Chain Structure of Antiviral Drug Packaging
Figure 75. Channels of Distribution
Figure 76. Global Antiviral Drug Packaging Sales Market Forecast by Region (2027-2032)
Figure 77. Global Antiviral Drug Packaging Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Antiviral Drug Packaging Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Antiviral Drug Packaging Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Antiviral Drug Packaging Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Antiviral Drug Packaging Revenue Market Share Forecast by Application (2027-2032)
